Yarkoni S - Search Results

1

Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice.

Yarkoni S, Kaminitz A, Sagiv Y, Askenasy N. Yarkoni S, et al. Diabetologia. 2010 Feb;53(2):356-68. doi: 10.1007/s00125-009-1604-4. Epub 2009 Nov 28. Diabetologia. 2010. PMID: 19946662

2

Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.

Yarkoni S, Sagiv Y, Kaminitz A, Farkas DL, Askenasy N. Yarkoni S, et al. Eur J Immunol. 2009 Oct;39(10):2850-64. doi: 10.1002/eji.200839190. Eur J Immunol. 2009. PMID: 19735074 Free article.

3

A fusion protein composed of IL-2 and caspase-3 ameliorates the outcome of experimental inflammatory colitis.

Sagiv Y, Kaminitz A, Lorberboum-Galski H, Askenasy N, Yarkoni S. Sagiv Y, et al. Among authors: yarkoni s. Ann N Y Acad Sci. 2009 Sep;1173:791-7. doi: 10.1111/j.1749-6632.2009.04877.x. Ann N Y Acad Sci. 2009. PMID: 19758230

4

Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycle.

Yarkoni S, Kaminitz A, Sagiv Y, Yaniv I, Askenasy N. Yarkoni S, et al. Bioessays. 2008 Sep;30(9):875-88. doi: 10.1002/bies.20812. Bioessays. 2008. PMID: 18693266

5

IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy.

Yarkoni S, Prigozhina TB, Slavin S, Askenasy N. Yarkoni S, et al. Biol Blood Marrow Transplant. 2012 Apr;18(4):523-35. doi: 10.1016/j.bbmt.2011.11.016. Epub 2012 Jan 3. Biol Blood Marrow Transplant. 2012. PMID: 22227590 Free article.

6

Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells.

Ash S, Yarkoni S, Askenasy N. Ash S, et al. Among authors: yarkoni s. Immunol Res. 2014 Jan;58(1):101-5. doi: 10.1007/s12026-013-8476-x. Immunol Res. 2014. PMID: 24371009 Review.

7

Mechanisms of T regulatory cell function.

Askenasy N, Kaminitz A, Yarkoni S. Askenasy N, et al. Among authors: yarkoni s. Autoimmun Rev. 2008 May;7(5):370-5. doi: 10.1016/j.autrev.2008.03.001. Epub 2008 Mar 24. Autoimmun Rev. 2008. PMID: 18486924 Review.

8

Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis.

Yarkoni S, Stein J, Yaniv I, Askenasy N. Yarkoni S, et al. Front Immunol. 2014 May 19;5:215. doi: 10.3389/fimmu.2014.00215. eCollection 2014. Front Immunol. 2014. PMID: 24904571 Free PMC article. Review.

9

Interleukin 2 targeted therapy in inflammatory bowel disease.

Yarkoni S, Sagiv Y, Kaminitz A, Askenasy N. Yarkoni S, et al. Gut. 2009 Dec;58(12):1705-6. doi: 10.1136/gut.2008.175182. Gut. 2009. PMID: 19923351 No abstract available.

10

Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression.

Yolcu ES, Ash S, Kaminitz A, Sagiv Y, Askenasy N, Yarkoni S. Yolcu ES, et al. Among authors: yarkoni s. Immunol Cell Biol. 2008 Nov-Dec;86(8):650-8. doi: 10.1038/icb.2008.62. Epub 2008 Sep 16. Immunol Cell Biol. 2008. PMID: 18794907 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters